Top Markets
#1 Black Phoenix Black Phoenix +736.30%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.93%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +17.76%
#4 MetaDAO MetaDAO +16.19%
#5 Verus Coin Verus Coin +13.95%
#6 Akedo Akedo +10.21%
#7 PondCoin PondCoin +6.99%
#8 wojak wojak +6.93%
#9 Quack AI Quack AI +6.35%
#10 MiL.k Alliance MiL.k Alliance +6.08%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Disc Medicine, Inc. Disc Medicine, Inc.

Disc Medicine, Inc.

IRON
Rank in Stocks #4917
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$82.54
Last synced: 2026-08-26
Market Cap
$3.17B
Change (1 day)
0.16%
Change (1 year)
37.68%
Country
US
Trade Disc Medicine, Inc. (IRON)

Category

Healthcare
P/E ratio for Disc Medicine, Inc. (IRON)
P/E ratio as of 2026 TTM: 0
According to Disc Medicine, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Disc Medicine, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.